Janux Therapeutics, Inc. logo JANX - Janux Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 12
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $30.14 DETAILS
HIGH: $55.00
LOW: $14.00
MEDIAN: $26.00
CONSENSUS: $30.14
UPSIDE: 82.56%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 10.3 3.7 0 10 0 0 0 0.4 8.9 1.3 2.5 2.5 1.1 2.0 2.8 1.8 2.4 1.6 1.6 1.2 0.5 0.4 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0.5 0.5 0.5 14.9 15.9 15.4 13.7 14.1 10.2 11.2 8.4 4.7 1.9 0 0 0 0
Gross Profit 10.3 3.7 0 10 0 0 0 0.4 8.9 0.7 1.9 2.0 (13.9) (13.8) (12.6) (11.9) (11.7) (8.6) (9.6) (7.2) (4.3) (1.5) 0 0 0 0
Operating Expenses
R&D Expenses 31.0 26.8 31.5 34.6 34.7 25.1 20.8 18.6 14.9 14.1 12.2 11.9 14.9 15.9 15.4 13.7 14.1 10.2 11.2 8.4 4.7 1.9 1.0 0.8 0.7 0.5
SG&A Expenses 11.0 11.1 10.9 10.6 10.5 9.8 8.2 17.7 7.8 6.8 6.4 6.4 6.9 6.5 5.7 6.1 5.5 4.9 3.9 3.7 2.0 0.7 0.7 0.4 0.4 0.3
Other Expenses 0 0 0 0 0 0 0 0 0 0 (0.5) (0.5) (14.9) (15.9) (15.4) (13.7) (14.1) (10.2) (11.2) (8.4) (4.7) (1.9) 0 0 0 0
Operating Expenses 42.0 37.9 42.4 45.3 45.1 34.9 29.0 36.3 22.7 20.9 18.1 17.8 6.9 6.5 5.7 6.1 5.5 4.9 3.9 3.7 2.0 0.7 1.7 1.3 1.1 0.8
Operating Income
Operating Income (31.7) (34.2) (42.4) (35.3) (45.1) (34.9) (29.0) (35.8) (13.8) (20.2) (16.1) (15.8) (20.7) (20.3) (18.3) (18.0) (17.3) (13.5) (13.5) (10.9) (6.3) (2.3) (1.7) (1.3) (1.1) (0.8)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1
Interest Income 9.7 9.9 10.5 10.9 11.3 11.4 8.8 7.8 7.9 5.4 4.4 4.2 3.2 2.8 2.2 1.3 0.4 0.1 0.1 0.1 0.0 0 0 0 0 0
Profitability
EBITDA (21.5) (23.9) (31.5) (23.8) (33.3) (23.0) (19.7) (27.5) (5.5) (14.2) (11.2) (11.1) (17.0) (17.0) (15.7) (16.4) (16.8) (13.3) (13.4) (10.7) (6.2) (2.3) (1.6) (1.3) (2.4) (1.3)
EBIT (22.0) (24.4) (31.9) (24.3) (33.9) (23.5) (20.2) (28.1) (6.0) (14.8) (11.8) (11.6) (17.5) (17.5) (16.1) (16.7) (16.9) (13.4) (13.4) (10.8) (6.2) (2.3) (1.7) (1.3) (2.4) (1.3)
Income Before Tax (22.0) (24.4) (31.9) (24.3) (33.9) (23.5) (20.2) (28.1) (6.0) (14.8) (11.8) (11.6) (17.5) (17.5) (16.1) (16.7) (16.9) (13.4) (13.4) (10.8) (6.2) (2.3) (1.7) (1.3) (2.5) (1.4)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (22.0) (24.4) (31.9) (24.3) (33.9) (23.5) (20.2) (28.1) (6.0) (14.8) (11.8) (11.6) (17.5) (17.5) (16.1) (16.7) (16.9) (13.4) (13.4) (10.8) (6.2) (2.3) (1.7) (1.3) (2.5) (1.4)
Per Share Data
EPS (Basic) -0.35 -0.39 -0.52 -0.39 -0.55 -0.38 -0.36 -0.51 -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 -0.39 -0.34 -0.40 -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 -0.20 -0.11
EPS (Diluted) -0.35 -0.39 -0.52 -0.39 -0.55 -0.38 -0.36 -0.51 -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 -0.39 -0.34 -0.40 -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 -0.20 -0.11
Shares Outstanding 62.9 62.7 62.0 62.0 61.9 61.8 53.8 54.6 54.5 49.0 46.7 45.7 41.8 41.8 41.6 41.5 41.4 41.3 41.2 41.1 10.0 39.9 12.5 12.5 12.5 12.5
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 27.8 51.8 52.3 48.4 52.4 73.7 430.6 26.8 14.7 212.8 19.2 17.2 33.7 30.4 51.4 64.8 58.4 55.1 35.6 39.4 251.6 70.8 7.8
Short-Term Investments 943.1 904.6 914.2 940.6 943.6 940.4 594.6 631.3 631.6 439.0 324.8 332.6 269.6 286.5 275.6 274.0 295.9 306.1 339.4 348.1 142.6 0 0
Net Receivables 6.3 42.5 6.4 6.3 5.7 5.6 5.4 4.5 12.1 4.4 2.2 1.7 1.5 1.4 0.7 0.5 0.3 0.1 0.2 0.0 0.4 0.4 8
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 0 0 0 0 0 0 0 0 0 3.0 3.8 4.5 3.1 4.7 0 3.5 3.4 1.9 2.1 2.0 0 0
Total Current Assets 983.3 1,002.0 975.9 998.1 1,005.6 1,023.3 1,033.7 666.3 661.9 658.7 349.2 355.2 309.3 321.4 332.4 344.3 358.1 364.7 377.0 389.6 396.6 71.4 16.1
Non-Current Assets
Property, Plant & Equipment 20.6 21.4 22.3 23.2 23.1 23.8 24.1 25.1 26.0 27.0 27.8 28.5 28.9 29.1 29.4 29.2 26.3 2.8 1.6 1.4 0.2 0.2 0.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0.8 0.8 0.8 0 0 0 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3.7 4.8 2.6 2.6 2.7 3.6 3.7 3.6 2.6 3.3 3.3 3.1 3.2 2.4 2.2 2.2 1.0 1.2 1.2 0.1 0 0.3 0
Total Non-Current Assets 24.3 26.2 31.6 26.7 26.7 27.4 27.9 28.7 29.5 30.3 31.2 31.7 32.2 31.6 31.6 31.4 27.3 3.9 2.8 1.5 0.2 0.4 0.2
Total Assets 1,007.7 1,028.2 1,007.5 1,024.8 1,032.2 1,050.8 1,061.5 695.0 691.4 689.0 380.4 386.9 341.5 353.0 364.0 375.8 385.4 368.6 379.8 391.1 396.8 71.8 16.2
Current Liabilities
Account Payables 3.0 3.4 5.0 3.4 3.5 2.4 4.0 2.5 1.3 2.3 2.4 2.5 1.9 2.1 2.2 2.9 3 1.9 2.5 3.6 0.4 0.9 0.4
Short-Term Debt 0 0 2.4 2.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 35.1 37.6 0 0 0 0 0 0 0.1 1.0 1.7 3.6 5.3 4.9 5.4 5.9 5.4 4.6 5.2 5.3 5.1 3.6 1.9
Other Current Liabilities 3.1 2.2 13.0 18.1 13.7 1.9 4.6 3.9 6.6 1.3 3.3 2.4 1.7 1.4 2.7 2.2 1.7 1.5 2.4 2.1 3.4 1.8 0.3
Total Current Liabilities 60.2 58.9 25.0 27.8 21.4 17.5 17.5 17.2 11.5 10.6 13.0 14.5 17.9 16.1 16.5 16.3 13.0 12.5 12.8 12.5 9.2 6.9 3.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 6.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 77.3 21.6
Total Non-Current Liabilities 19.5 27.8 25.7 20.4 20.3 20.8 21.3 21.7 22.2 22.6 23.0 23.4 24.1 25.6 26.8 27.9 28.6 0 0.7 1.9 2.8 81.7 27.7
Total Liabilities 79.7 86.7 50.7 48.2 41.7 38.3 38.7 38.9 33.7 33.2 36.1 37.9 42.0 41.7 43.3 44.2 41.6 12.5 13.5 14.3 12.0 88.6 30.9
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (397.7) (375.7) (351.4) (319.4) (295.1) (261.3) (237.8) (217.5) (189.5) (183.5) (168.8) (157.0) (145.4) (127.9) (110.5) (94.4) (77.7) (60.8) (47.4) (34.0) (23.2) (17.0) (14.7)
Accumulated Other Comprehensive Income (2.3) 0.6 4.3 4.6 3.7 3.8 2.2 7.8 (1.6) (0.5) 0.7 (1.2) (1.1) (0.7) (1.5) (2.3) (1.9) (1.6) (0.3) 0.0 0.0 0 0
Total Stockholders' Equity 928.0 941.5 956.8 976.6 990.5 1,012.5 1,022.8 656.1 657.7 655.8 344.3 348.9 299.5 311.3 320.7 331.5 343.8 356.1 366.3 376.8 384.8 (16.8) (14.6)
Total Liabilities & Equity 1,007.7 1,028.2 1,007.5 1,024.8 1,032.2 1,050.8 1,061.5 695.0 691.4 689.0 380.4 386.9 341.5 353.0 364.0 375.8 385.4 368.6 379.8 391.1 396.8 71.8 16.2
Debt Metrics
Total Debt 21.0 21.6 22.1 22.7 22.2 22.6 23.0 23.4 23.8 24.2 24.5 24.9 25.2 25.5 25.3 24.1 23.4 0.2 0.2 0.2 0 0 0
Net Debt (6.8) (30.3) (30.2) (25.7) (30.3) (51.1) (407.6) (3.3) 9.2 (188.6) 5.3 7.7 (8.5) (4.8) (26.1) (40.7) (35.0) (55.0) (35.4) (39.2) (251.6) (70.8) (7.8)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (22.0) (24.4) (31.9) (24.3) (33.9) (23.5) (20.2) (28.1) (6.0) (14.8) (11.8) (11.6) (17.5) (17.5) (16.1) (16.7) (16.9) (13.4) (13.4) (10.8) (6.2) (2.3) (1.7) (1.3) (2.5) (1.4)
Depreciation & Amortization 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 9.1 9.3 9.5 9.0 11.0 10.7 6.3 15.4 5.8 5.6 4.5 4.5 5.5 5.5 4.2 4.6 4.4 4.0 2.9 2.6 1.3 0.1 0.0 0.0 0.0 0.0
Change in Working Capital 27.8 4.9 (3.1) 6.5 3.8 (0.5) (0.3) 12.8 (7.4) (4.4) (1.1) (3.1) (1.7) (0.7) 0.8 (0.8) 6.4 (2.1) (0.0) 2.4 (1.3) 7.7 (0.0) 0.1 0.3 (0.1)
Other Non-Cash Items (2.9) (2.6) (3.5) (4.6) (5.2) (4.2) (2.9) (2.9) (3.0) (1.8) (2.1) (2.1) (1.8) (1.7) (1.3) (0.8) (0.1) (0.0) (0.1) (0.1) (0.0) 0 0 0 1.4 0.6
Operating Cash Flow 12.5 (12.3) (28.5) (12.9) (23.8) (17.0) (16.7) (2.2) (10.0) (14.8) (9.9) (11.7) (15.1) (13.9) (11.9) (13.4) (6.1) (11.5) (10.5) (5.9) (6.2) 5.6 (1.6) (1.1) (0.8) (0.9)
Investing Activities
Capital Expenditure (0.2) (0.3) (0.1) (0.1) (0.5) (0.4) (0.0) (0.0) (0.1) (0.2) (0.5) (0.5) (0.6) (0.3) (2.1) (2.5) (0.9) (1.0) (1.2) (0.1) (0.1) (0.2) 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 (11.6) 61.0 0 0 0 (22.3) 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (144.8) (112.8) (123.3) (118.0) (92.7) (371.3) (24.0) (32.5) (235.5) (178.5) (33.1) (136.0) (76.5) (71.7) (86.0) (94.5) (68.8) (45.1) (103.5) (227.6) (142.5) 0 0 0 0 0
Sales/Maturities of Investments 106.3 121.3 152.9 126.4 94.7 31.3 58 45.2 44.8 65 44.8 75 95 63.2 86.5 116.8 78.8 77.1 112 22.1 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 11.6 (61.0) 0 0 0 22.3 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (38.8) 8.3 29.5 8.3 1.6 (340.4) 33.9 12.7 (190.9) (113.7) 11.1 (61.5) 17.9 (8.7) (1.6) 19.8 9.0 31.1 7.3 (205.5) (142.6) (0.2) 0 0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1.5
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 8.4 0 3.2 1.7 0 0.1 0 0 0 0 0 0 0 0 205.1 1.5 0.1 0 0 0.0
Financing Cash Flow 2.2 3.5 2.9 0.5 1.0 0.6 386.6 1.6 2.8 322.2 0.8 56.6 0.5 1.6 0.2 0 0.3 0.0 0.2 (0.8) 329.7 57.5 4.6 (0.0) 5.5 1.5
Cash Position
Net Change in Cash (24.1) (0.5) 3.9 (4.1) (21.3) (356.9) 403.9 12.1 (198.1) 193.6 2.1 (16.6) 3.3 (21.1) (13.3) 6.3 3.3 19.5 (3.8) (212.2) 180.9 63.0 2.9 (1.1) 4.7 0.6
Cash at Beginning 52.6 52.3 49.2 53.3 74.6 431.4 27.6 14.7 213.6 19.2 18.0 34.5 31.2 51.4 65.6 59.2 55.1 35.6 39.4 251.6 70.8 7.8 4.9 6.0 1.3 0.7
Cash at End 28.6 51.8 53.1 49.2 53.3 74.6 431.4 26.8 15.5 212.8 20.0 18.0 34.5 30.4 52.2 65.6 58.4 55.1 35.6 39.4 251.6 70.8 7.8 4.9 6.0 1.3
Free Cash Flow 12.3 (12.6) (28.6) (12.9) (24.3) (17.4) (16.8) (2.3) (10.1) (15.0) (10.4) (12.2) (15.6) (14.2) (14.0) (15.9) (7.0) (12.5) (11.7) (5.9) (6.3) 5.4 (1.6) (1.1) (0.8) (0.9)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 10.3 3.7 0 10 0 0 0 0.4 8.9 1.3 2.5 2.5 1.1 2.0 2.8 1.8 2.4 1.6 1.6 1.2 0.5 0.4 0 0 0 0
Gross Profit 10.3 3.7 0 10 0 0 0 0.4 8.9 0.7 1.9 2.0 (13.9) (13.8) (12.6) (11.9) (11.7) (8.6) (9.6) (7.2) (4.3) (1.5) 0 0 0 0
Operating Income (31.7) (34.2) (42.4) (35.3) (45.1) (34.9) (29.0) (35.8) (13.8) (20.2) (16.1) (15.8) (20.7) (20.3) (18.3) (18.0) (17.3) (13.5) (13.5) (10.9) (6.3) (2.3) (1.7) (1.3) (1.1) (0.8)
Net Income (22.0) (24.4) (31.9) (24.3) (33.9) (23.5) (20.2) (28.1) (6.0) (14.8) (11.8) (11.6) (17.5) (17.5) (16.1) (16.7) (16.9) (13.4) (13.4) (10.8) (6.2) (2.3) (1.7) (1.3) (2.5) (1.4)
EPS (Diluted) -0.35 -0.39 -0.52 -0.39 -0.55 -0.38 -0.36 -0.51 -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 -0.39 -0.34 -0.40 -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 -0.20 -0.11
Balance Sheet
Cash & Equivalents 27.8 51.8 52.3 48.4 52.4 73.7 430.6 26.8 14.7 212.8 19.2 17.2 33.7 30.4 51.4 64.8 58.4 55.1 35.6 39.4 251.6 70.8 7.8
Total Assets 1,007.7 1,028.2 1,007.5 1,024.8 1,032.2 1,050.8 1,061.5 695.0 691.4 689.0 380.4 386.9 341.5 353.0 364.0 375.8 385.4 368.6 379.8 391.1 396.8 71.8 16.2
Total Debt 21.0 21.6 22.1 22.7 22.2 22.6 23.0 23.4 23.8 24.2 24.5 24.9 25.2 25.5 25.3 24.1 23.4 0.2 0.2 0.2 0 0 0
Stockholders' Equity 928.0 941.5 956.8 976.6 990.5 1,012.5 1,022.8 656.1 657.7 655.8 344.3 348.9 299.5 311.3 320.7 331.5 343.8 356.1 366.3 376.8 384.8 (16.8) (14.6)
Cash Flow
Operating Cash Flow 12.5 (12.3) (28.5) (12.9) (23.8) (17.0) (16.7) (2.2) (10.0) (14.8) (9.9) (11.7) (15.1) (13.9) (11.9) (13.4) (6.1) (11.5) (10.5) (5.9) (6.2) 5.6 (1.6) (1.1) (0.8) (0.9)
Capital Expenditure (0.2) (0.3) (0.1) (0.1) (0.5) (0.4) (0.0) (0.0) (0.1) (0.2) (0.5) (0.5) (0.6) (0.3) (2.1) (2.5) (0.9) (1.0) (1.2) (0.1) (0.1) (0.2) 0 0 0 0
Free Cash Flow 12.3 (12.6) (28.6) (12.9) (24.3) (17.4) (16.8) (2.3) (10.1) (15.0) (10.4) (12.2) (15.6) (14.2) (14.0) (15.9) (7.0) (12.5) (11.7) (5.9) (6.3) 5.4 (1.6) (1.1) (0.8) (0.9)